Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, shared a post on X:
“10y results of FAST FORWARD (adjuvant breast cancer RT) trial presented at ESTRO25 by AM Brunt.
Compared to 40Gy/15, 26Gy/5:
1. Non inf for IBR (even superior?)
2. Similar recurrence free interval, breast cancer interval, OS
3. No diff in PRO or toxicityClearly 26/5 SOC for.”
ESTRO 2025 Live Updates on OncoDaily.